Research Reports Initiated on Healthcare Stocks Patient Home Monitoring, Zecotek Photonics, Theralase Technologies, and Hamilton Thorne

LONDON, UK / ACCESSWIRE / February 7, 2017 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Medical Devices industry. Companies recently under review include Patient Home Monitoring, Zecotek Photonics, Theralase Technologies, and Hamilton Thorne. Get all of our free research reports by signing up at:

http://www.activewallst.com/register/

On Monday, February 06, 2017, at the end of trading session, the TSX Venture Composite index ended the day at 826.37, 0.87% higher, on a total volume of 254,319,406 shares.

Additionally, the Healthcare index was up by 1.44%, ending the session at 71.00.

Active Wall St. has initiated research reports on the following equities: Patient Home Monitoring Corporation (TSX-V: PHM), Zecotek Photonics Inc. (TSX-V: ZMS), Theralase Technologies Inc. (TSX-V: TLT), and Hamilton Thorne Ltd (TSX-V: HTL). Register with us now for your free membership and research reports at:

http://www.activewallst.com/register/

Patient Home Monitoring Corp.

Lafayette, Louisiana headquartered Patient Home Monitoring Corp.'s stock declined 3.45%, to finish Monday's session at $0.14 with a total volume of 201,077 shares traded. Shares of the Company, which provides and rents in-home monitoring equipment, supplies, and services for patients in the US, are trading below its 50-day and 200-day moving averages. Patient Home Monitoring's 200-day moving average of $0.17 is above its 50-day moving average of $0.15. See our research report on PHM.V at:

http://www.activewallst.com/registration-3/?symbol=PHM

Zecotek Photonics Inc.

On Monday, shares in Richmond, Canada headquartered Zecotek Photonics Inc. recorded a trading volume of 189,800 shares. The stock ended the day 3.85% lower at $0.25. Shares of the Company, which develops various photonics technologies and products for commercial and research applications in medical, bio-science, high-energy physics, pharmaceutical research, material processing, engineering and industrial design, and multi-media markets, are trading below its 50-day and 200-day moving averages. The stock's 200-day moving average of $0.27 is above its 50-day moving average of $0.26. The complimentary research report on ZMS.V at:

http://www.activewallst.com/registration-3/?symbol=ZMS

Theralase Technologies Inc.

On Monday, shares in Toronto, Canada-based Theralase Technologies Inc. ended the session 1.75% higher at $0.29 with a total volume of 291,588 shares traded. Shares of the Company, which designs, develops, manufactures, and markets super-pulsed cold laser technology for a range of human, companion animal, and equine applications, are trading below its 50-day and 200-day moving averages. Furthermore, the stock's 200-day moving average of $0.35 is greater than its 50-day moving average of $0.31. Register for free and access the latest research report on TLT.V at:

http://www.activewallst.com/registration-3/?symbol=TLT

Hamilton Thorne Ltd.

Toronto, Canada-based Hamilton Thorne Ltd.'s stock fell 5.26%, to close the day at $0.45. The stock recorded a trading volume of 39,981 shares. Hamilton Thorne's shares have surged 45.16% in the last three months and 143.24% in the past one year. The company's shares are trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $0.46 is greater than its 200-day moving average of $0.32. Shares of the Company, which together with its subsidiary, Hamilton Thorne, Inc., develops, manufactures, and sells precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell, and developmental biology research markets, are trading at a PE ratio of 56.25. Get free access to your research report on HTL.V at:

http://www.activewallst.com/registration-3/?symbol=HTL

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street